2 Reasons to Sell OPCH and 1 Stock to Buy Instead

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

OPCH Cover Image

Shareholders of Option Care Health would probably like to forget the past six months even happened. The stock dropped 32.6% and now trades at $20.85. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

Is there a buying opportunity in Option Care Health, or does it present a risk to your portfolio? Check out our in-depth research report to see what our analysts have to say, it’s free.

Why Is Option Care Health Not Exciting?

Despite the more favorable entry price, we’re cautious about Option Care Health. Here are two reasons we avoid OPCH, plus one stock we’d rather own.

1. Projected Revenue Growth Is Slim

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite.

Over the next 12 months, sell-side analysts expect Option Care Health’s revenue to rise by 2.5%, a deceleration versus its 12.9% annualized growth for the past five years. This projection is underwhelming and indicates its products and services will see some demand headwinds.

2. Free Cash Flow Margin Dropping

If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills.

As you can see below, Option Care Health’s margin dropped by 1.7 percentage points over the last five years. If its declines continue, it could signal increasing investment needs and capital intensity. Option Care Health’s free cash flow margin for the trailing 12 months was 3.8%.

Option Care Health Trailing 12-Month Free Cash Flow Margin

Final Judgment

Option Care Health isn’t a terrible business, but it doesn’t pass our quality test. Following the recent decline, the stock trades at 10.9× forward P/E (or $20.85 per share). This valuation is reasonable, but the company’s shakier fundamentals present too much downside risk. We’re fairly confident there are better stocks to buy right now. We’d suggest looking at the most dominant software business in the world.

Stocks We Like More Than Option Care Health

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  262.24
-8.40 (-3.11%)
AAPL  306.28
-5.78 (-1.85%)
AMD  509.40
-6.70 (-1.30%)
BAC  51.55
-0.05 (-0.11%)
GOOG  371.66
-4.77 (-1.27%)
META  611.57
-20.94 (-3.31%)
MSFT  461.67
+11.43 (2.54%)
NVDA  222.09
+10.95 (5.19%)
ORCL  245.91
+20.13 (8.92%)
TSLA  420.94
-14.85 (-3.41%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.